ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
CELG,Celgene Corp.,151020104,308162000.0,1999271,16.766916025043567,2013-11-12,2013-09-30,0000950123-13-009068
N/A,"Isis Pharmaceuticals, Inc.",464330109,270385000.0,7202585,14.71149132414576,2013-11-12,2013-09-30,0000950123-13-009068
GILD,"Gilead Sciences, Inc",375558103,228074000.0,3627714,12.409374307980176,2013-11-12,2013-09-30,0000950123-13-009068
INCY,Incyte Corp.,45337C102,181719000.0,4763270,9.887225592885859,2013-11-12,2013-09-30,0000950123-13-009068
VRTX,Vertex Pharmaceuticals Inc.,92532F100,106485000.0,1404445,5.793787205842266,2013-11-12,2013-09-30,0000950123-13-009068
ALXN,"Alexion Pharmaceuticals, Inc.",015351109,87983000.0,757428,4.787104096648543,2013-11-12,2013-09-30,0000950123-13-009068
N/A,"Medivation, Inc.",58501N101,86895000.0,1449706,4.727906646491653,2013-11-12,2013-09-30,0000950123-13-009068
N/A,"Ariad Pharmaceuticals, Inc.",04033A100,67879000.0,3689071,3.693257094852488,2013-11-12,2013-09-30,0000950123-13-009068
HALO,"Halozyme Therapeutics, Inc.",40637H109,60900000.0,5516322,3.3135337449950133,2013-11-12,2013-09-30,0000950123-13-009068
IMGNEUR,"ImmunoGen, Inc.",45253H101,55754000.0,3275816,3.03354286401399,2013-11-12,2013-09-30,0000950123-13-009068
N/A,"Pharmacyclics, Inc.",716933106,55170000.0,399030,3.0017677620915415,2013-11-12,2013-09-30,0000950123-13-009068
N/A,Synageva BioPharma Corp.,87159A103,45300000.0,714602,2.464746775833729,2013-11-12,2013-09-30,0000950123-13-009068
N/A,"Onyx Pharmaceuticals, Inc.",683399109,42382000.0,339870,2.305980085063689,2013-11-12,2013-09-30,0000950123-13-009068
N/A,"Theravance, Inc.",88338T104,36303000.0,888244,1.9752252141962883,2013-11-12,2013-09-30,0000950123-13-009068
REGN,"Regeneron Pharmaceuticals, Inc.",75886F107,31913000.0,102000,1.736367855566927,2013-11-12,2013-09-30,0000950123-13-009068
N/A,"Endocyte, Inc.",29269A102,30250000.0,2269345,1.6458849882774902,2013-11-12,2013-09-30,0000950123-13-009068
ALNY,"Alnylam Pharmaceuticals, Inc.",02043Q107,30167000.0,471288,1.6413690063261834,2013-11-12,2013-09-30,0000950123-13-009068
CLVSEUR,Clovis Oncology Inc.,189464100,23219000.0,381886,1.2633323485228114,2013-11-12,2013-09-30,0000950123-13-009068
INFIQ,Infinity Pharmaceuticals Inc.,45665G303,22672000.0,1300737,1.2335703951810664,2013-11-12,2013-09-30,0000950123-13-009068
NBIX,"Neurocrine Biosciences, Inc.",64125C109,22076000.0,1950148,1.2011423802054173,2013-11-12,2013-09-30,0000950123-13-009068
N/A,"Optimer Pharmaceuticals, Inc.",68401H104,17905000.0,1422200,0.9742006847969739,2013-11-12,2013-09-30,0000950123-13-009068
T8S,"Tesaro, Inc.",881569107,14462000.0,373300,0.7868690479493906,2013-11-12,2013-09-30,0000950123-13-009068
N/A,"Idenix Pharmaceuticals, Inc.",45166R204,6488000.0,1250000,0.35300832409733407,2013-11-12,2013-09-30,0000950123-13-009068
ACHNEUR,"Achillion Pharmaceuticals, Inc.",00448Q201,5374000.0,1779340,0.29239622899184237,2013-11-12,2013-09-30,0000950123-13-009068
